TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PDSB

PDS Biotechnology Corp

Healthcare · Biotechnology

0.8055$ -4.4% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns PDS Biotechnology Corp (PDSB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.3% of the shares are freely tradable; institutional investors hold 9.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 9.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 75.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 73Mio.

Largest Shareholders

Institutions

Institutions PDSB
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 2.91 1,631,089 +0.0 03/31/2026
Geode Capital Management, LLC 1.18 660,228 +26.9 03/31/2026
BlackRock Inc 0.99 554,048 +6.1 03/31/2026
Militia Capital Management, LLC 0.59 331,800 +0.0 06/30/2026
Citadel Advisors Llc 0.58 323,801 +0.0 06/30/2026
Vanguard Fiduciary Trust Co 0.55 307,311 +0.0 03/31/2026
Blair William & Co 0.54 300,000 +0.0 06/30/2026

Funds

Funds PDSB
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.86 1,042,050 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 1.04 583,951 +0.0 07/31/2026
Fidelity Extended Market Index 0.52 290,948 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?